Logo
x

Search

Subscribe Now

inflammatory bowel disease

Genentech Enters into a Multi-Year Research Collaboration with Novome Biotechnologies to Develop Targets Against Inflammatory Bowel Disease

Genentech Enters into a Multi-Year Research Collaboration with Novome Biotechnologies to Develop Targets Against Inflammatory Bowe...

  • November 11, 2021
AzurRx Signs a Reverse Triangular Merger Agreement to Acquire First Wave Bio for ~$229M

AzurRx Signs a Reverse Triangular Merger Agreement to Acquire First Wave Bio for ~$229M

  • September 14, 2021
Boehringer Ingelheim Collaborates with BiomX to Discover Microbiome-Based Biomarkers for Inflammatory Bowel Disease

Boehringer Ingelheim Collaborates with BiomX to Discover Microbiome-Based Biomarkers for Inflammatory Bowel Disease

  • September 3, 2020
Celltrion's Remsima SC (biosimilar- infliximab) Receives CHMP's Positive Opinion for an Additional Five Indications Including Inflammatory Bowel Disease and Ankylosing Spondylitis

Celltrion's Remsima SC (biosimilar- infliximab) Receives CHMP's Positive Opinion for an Additional Five Indications Including Infl...

  • June 30, 2020
Synlogic Terminates its Agreement with AbbVie for Synthetic Biotic Medicines to Treat Inflammatory Bowel Disease

Synlogic Terminates its Agreement with AbbVie for Synthetic Biotic Medicines to Treat Inflammatory Bowel Disease

  • May 21, 2020
Gilead Sciences and Second Genome Signs a Four-Year Collaboration to Identify Biomarkers and Therapies Targeting Inflammatory Bowel Disease

Gilead Sciences and Second Genome Signs a Four-Year Collaboration to Identify Biomarkers and Therapies Targeting Inflammatory Bowe...

  • April 6, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.